title: In vivo binding of 125I-LSD to serotonin 5-HT2 receptors in mouse brain.
abstract: The binding of 125I-LSD (2-[125I]-lysergic acid diethylamide) was studied in various mouse brain regions following intravenous injection of the radioligand. The high specific activity of 125I-LSD enabled the injection of low mass doses (14 ng/kg), which are well below the threshold for induction of any known physiological effect of the probe. The highest levels of 125I-LSD binding were found in the frontal cortex, olfactory tubercles, extra-frontal cortex and striatum while the lowest level was found in the cerebellum. Binding was saturable in the frontal cortex but increased linearly in the cerebellum with increasing doses of 125I-LSD. Serotonergic compounds potently inhibited 125I-LSD binding in cortical regions, olfactory tubercles, and hypothalamus but had no effect in the cerebellum. Dopaminergic compounds caused partial inhibition of binding in the striatum while adrenergic compounds were inactive. From these studies we conclude that 125I-LSD labels serotonin 5-HT2 receptor sites in cortical regions with no indication that other receptor sites are labeled. In the olfactory tubercles and hypothalamus, 125I-LSD labeling occurs predominantly or entirely at serotonin 5-HT2 sites. In the striatum, 125I-LSD labels approximately equal proportions of serotonergic and dopaminergic sites. This data indicates that 125I-LSD labels serotonin receptors in vivo and suggests that appropriate derivatives of 2I-LSD may prove useful for tomographic imaging of serotonin 5-HT2 receptors in the mammalian cortex.
authors.forename: P R
authors.initials: PR
authors.lastname: Hartig
authors.forename: U
authors.initials: U
authors.lastname: Scheffel
authors.forename: J J
authors.initials: JJ
authors.lastname: Frost
authors.forename: H N
authors.initials: HN
authors.lastname: Wagner
mesh_terms: D000818:Animals; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism*; D002928:Cinanserin / Q000378:metabolism; D007650:Ketanserin; D008238:Lysergic Acid Diethylamide / Q000378:metabolism*; D008803:Mianserin / Q000378:metabolism; D051379:Mice; D010880:Piperidines / Q000378:metabolism; D011985:Receptors, Serotonin / Q000378:metabolism*; D013134:Spiperone / Q000378:metabolism; D013997:Time Factors; D014018:Tissue Distribution
chemical_list: D010880:Piperidines; D011985:Receptors, Serotonin; D008803:Mianserin; D013134:Spiperone; D008238:Lysergic Acid Diethylamide; D007650:Ketanserin; D002928:Cinanserin